BioSpace News Archive

Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Market: Rise in prevalence of colorectal cancer to drive the market

Albany NY, United States: Gastroenteropancreatic neuroendocrine tumors are a large and differing group of uncommon and complex neoplasms.

April 4, 2022
·
5 min read
Ovulation Inducing Drugs Market: Rise in Number of Patients Opting for IVF is Likely to Fuel the Growth Market

Albany NY, United States: Changing lifestyle, medicinal adverse effects, delayed pregnancy, and comorbidities are affecting natural reproduction among the human population.

April 4, 2022
·
5 min read
Biotech Bay

New Data for Genentech’s Ocrevus (ocrelizumab) Show Benefit in Disability Progression and Cognitive Decline in Both Secondary Progressive and Primary Progressive Multiple Sclerosis

Genentech, a member of the Roche Group, announced new Ocrevus® data that show its benefit on disease progression and cognitive outcomes in primary progressive multiple sclerosis and secondary progressive MS.

April 4, 2022
·
14 min read
Business

Skanska renovates and expands acute care services facility for hospital in Virginia, USA, for USD 78M, about SEK 720M

Skanska has signed a contract with Bon Secours - St. Francis Medical Center, Inc. to renovate and expand an acute care services facility in Midlothian, Virginia, USA.

April 4, 2022
·
1 min read
Genetown

Annexon Biosciences to Participate in the 21st Annual Needham Virtual Healthcare Conference

Annexon, Inc. announced that Douglas Love, Esq., president & chief executive officer, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022 at 3:45 p.m. ET.

April 4, 2022
·
1 min read
Genetown

Mustang Bio to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities

Mustang Bio, Inc. today announced that members of Mustang’s management team will participate in the two-day Fortress Biotech (“Fortress”) Virtual R&D Summit taking place on Tuesday, April 5, 2022.

April 4, 2022
·
3 min read
Genetown

X4 Pharmaceuticals to Present at April Investor Conferences

X4 Pharmaceuticals, Inc. today announced that management will present a corporate overview at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022.

April 4, 2022
·
2 min read
Policy

Aziyo Announces FDA 510(k) Submission for CanGaroo® RM, its Next-Generation Biomaterial Envelope Enhanced with Antibiotics

Aziyo Biologics, Inc., announced the Company has filed a 510 premarket notification to the U.S. Food and Drug Administration for CanGaroo® RM Antibacterial Envelope, its next-generation biomaterial envelope for use with implantable electronic devices.

April 4, 2022
·
4 min read
Biotech Bay

Aligos Therapeutics Selects Drug Candidate ALG-097558, a Potent Ritonavir-Free Oral Protease Inhibitor for the Treatment and Prevention of COVID-19

Aligos Therapeutics, Inc. today announced that it has selected ALG-097558, a broad spectrum coronavirus protease inhibitor, as its drug candidate to move forward into development.

April 4, 2022
·
7 min read
Pharm Country

BioRestorative Therapies Announces cGMP Cell Manufacturing Facility Certification

BioRestorative Therapies, Inc., a clinical stage company focused on stem cell-based therapies, announced that it has completed testing and certification of its clinical grade cell therapy manufacturing facility.

April 4, 2022
·
4 min read